Dermapharm Holding SE (LON: 0A5J)

Dermapharm Holding SE Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jan 17, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,840	1,978	1,792	4,038	2,748	1,813
Market Cap Growth	-14.28%	10.40%	-55.63%	46.97%	51.52%	65.17%
Enterprise Value	2,610	2,827	2,211	4,446	3,211	2,202
Last Close Price	34.13	35.98	31.77	69.01	46.34	-
PE Ratio	24.41	36.55	15.05	22.94	35.73	27.72
PS Ratio	1.60	1.98	1.94	5.01	3.79	3.00
PB Ratio	3.19	4.18	3.79	9.62	9.45	7.52
P/TBV Ratio	-	-	41.95	310.95	-	-
P/FCF Ratio	11.98	12.82	8.10	25.42	33.96	39.51
P/OCF Ratio	9.56	10.39	7.00	19.20	23.39	21.27
EV/Sales Ratio	2.63	2.83	2.40	5.51	4.43	3.64
EV/EBITDA Ratio	12.78	14.79	8.25	16.95	23.11	19.86
EV/EBIT Ratio	14.36	16.87	8.82	17.89	25.58	21.58
EV/FCF Ratio	19.96	18.31	9.99	27.98	39.69	47.98
Debt / Equity Ratio	1.74	1.98	0.97	1.16	1.87	1.95
Debt / EBITDA Ratio	4.26	4.77	1.69	1.83	3.81	4.11
Debt / FCF Ratio	6.53	6.07	2.07	3.07	6.72	10.24
Asset Turnover	0.55	0.64	0.74	0.73	0.71	0.82
Inventory Turnover	1.29	1.55	1.57	1.56	1.86	2.30
Quick Ratio	0.65	0.75	1.18	1.61	1.39	1.68
Current Ratio	1.66	1.60	2.45	3.34	3.01	3.45
Return on Equity (ROE)	15.75%	11.24%	25.69%	50.68%	28.22%	28.79%
Return on Assets (ROA)	6.26%	6.76%	12.53%	14.06%	7.72%	8.61%
Return on Capital (ROIC)	8.23%	9.03%	16.60%	18.39%	9.89%	10.76%
Earnings Yield	4.10%	2.74%	6.65%	4.36%	2.80%	3.61%
FCF Yield	7.11%	7.80%	12.35%	3.93%	2.94%	2.53%
Dividend Yield	2.51%	2.12%	2.93%	2.64%	1.70%	-
Payout Ratio	52.30%	90.64%	87.04%	22.61%	50.19%	53.70%
Buyback Yield / Dilution	-0.23%	-	-	-	-	-0.79%
Total Shareholder Return	-0.23%	2.12%	2.93%	2.64%	1.70%	-0.79%

Source: S&P Capital IQ. Standard template. Financial Sources.